APA (7th ed.) Citation

Kalkner, K. M., Acosta, S., Thorsson, O., Frederiksen, H., Nilsson, A., Gustavsson, B., . . . Abrahamsson, P. (2006). Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer. Prostate Cancer & Prostatic Diseases, 9(1), 92. https://doi.org/10.1038/sj.pcan.4500843

Chicago Style (17th ed.) Citation

Kalkner, K. M., S. Acosta, O. Thorsson, H. Frederiksen, A. Nilsson, B. Gustavsson, M. Elingsbo, M. Stridsberg, and P-A Abrahamsson. "Octreotide Scintigraphy and Chromogranin A Do Not Predict Clinical Response in Patients with Octreotide Acetate-treated Hormone-refractory Prostate Cancer." Prostate Cancer & Prostatic Diseases 9, no. 1 (2006): 92. https://doi.org/10.1038/sj.pcan.4500843.

MLA (9th ed.) Citation

Kalkner, K. M., et al. "Octreotide Scintigraphy and Chromogranin A Do Not Predict Clinical Response in Patients with Octreotide Acetate-treated Hormone-refractory Prostate Cancer." Prostate Cancer & Prostatic Diseases, vol. 9, no. 1, 2006, p. 92, https://doi.org/10.1038/sj.pcan.4500843.